How Value Analysis Committees’ Lines of Questioning Can Directly Affect Value Equation Outputs

By AHRMM

John Kelty from W.L. Gore & Associates discusses how value analysis committees can determine a medical devices value when evaluating new products. 

Related Resources

Webcast
Karen Conway, Vice President, Healthcare Value at GHX and Mike Schiller, Senior Director of Supply Chain at AHRMM discuss the value of UDI beyond r
Webcast
AHRMM presents a four-part series on successful collaboration with suppliers.
Book
This book was written to enhance the strategic contributions of the healthcare supply chain in a way that is most meaningful to hospitals’ an
White Papers
AHRMM19 CQO Summit White Paper entitled CQO: The Power of Clinical Integration.
Podcasts
In this three-part webcast, Howard Mann, Vice President, Supply Chain Management at Cardiovascular Care Group discusses the basics and relationship
On-Demand Educational Webinars
Business continuity ensures that an organization can continue to operate in the event of a serious incident or disaster and encompasses strategic…